1. Home
  2. RGNX vs WDI Comparison

RGNX vs WDI Comparison

Compare RGNX & WDI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RGNX
  • WDI
  • Stock Information
  • Founded
  • RGNX 2008
  • WDI 2021
  • Country
  • RGNX United States
  • WDI United States
  • Employees
  • RGNX N/A
  • WDI N/A
  • Industry
  • RGNX Biotechnology: Biological Products (No Diagnostic Substances)
  • WDI Trusts Except Educational Religious and Charitable
  • Sector
  • RGNX Health Care
  • WDI Finance
  • Exchange
  • RGNX Nasdaq
  • WDI Nasdaq
  • Market Cap
  • RGNX 661.2M
  • WDI 788.9M
  • IPO Year
  • RGNX 2015
  • WDI N/A
  • Fundamental
  • Price
  • RGNX $13.08
  • WDI $14.46
  • Analyst Decision
  • RGNX Strong Buy
  • WDI
  • Analyst Count
  • RGNX 7
  • WDI 0
  • Target Price
  • RGNX $30.00
  • WDI N/A
  • AVG Volume (30 Days)
  • RGNX 602.9K
  • WDI 192.6K
  • Earning Date
  • RGNX 11-06-2025
  • WDI 01-01-0001
  • Dividend Yield
  • RGNX N/A
  • WDI 11.80%
  • EPS Growth
  • RGNX N/A
  • WDI N/A
  • EPS
  • RGNX N/A
  • WDI 1.12
  • Revenue
  • RGNX $155,782,000.00
  • WDI N/A
  • Revenue This Year
  • RGNX $198.02
  • WDI N/A
  • Revenue Next Year
  • RGNX $2.67
  • WDI N/A
  • P/E Ratio
  • RGNX N/A
  • WDI $12.82
  • Revenue Growth
  • RGNX 74.95
  • WDI N/A
  • 52 Week Low
  • RGNX $5.04
  • WDI $12.16
  • 52 Week High
  • RGNX $13.93
  • WDI $14.69
  • Technical
  • Relative Strength Index (RSI)
  • RGNX 57.58
  • WDI 32.56
  • Support Level
  • RGNX $12.66
  • WDI $14.15
  • Resistance Level
  • RGNX $13.93
  • WDI $14.61
  • Average True Range (ATR)
  • RGNX 0.69
  • WDI 0.18
  • MACD
  • RGNX -0.05
  • WDI -0.02
  • Stochastic Oscillator
  • RGNX 57.85
  • WDI 33.52

About RGNX REGENXBIO Inc.

Regenxbio Inc is a biotechnology company. Its main activity is the development and commercialization of recombinant adeno associated virus gene therapy to correct an underlying genetic defect. The diseases that the Regenxbio platform targets are metabolic (homozygous familial hypercholesterolemia), neurodegenerative conditions (mucopolysaccharidosis), and retinal diseases (wet age-related macular degeneration, X-linked retinitis pigmentosa). The company derives the majority of its revenue from the United States.

About WDI Western Asset Diversified Income Fund of Beneficial Interest

Western Asset Diversified Income Fund is a newly-organized, diversified, closed-end management investment company. The fund's primary investment objective is to seek high current income.

Share on Social Networks: